George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 190.00
Ask: 240.00
Change: -9.00 (-4.19%)
Spread: 50.00 (26.316%)
Open: 215.00
High: 206.00
Low: 206.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2017 Interim Management Statement

29 Jun 2017 07:00

JZ Capital Partners Ltd - Q1 2017 Interim Management Statement

JZ Capital Partners Ltd - Q1 2017 Interim Management Statement

PR Newswire

London, June 29

JZ CAPITAL PARTNERS LIMITED(a closed-end investment company incorporated with limited liability under the laws of Guernsey with registered number 48761)

 Q1 2017 Interim Management Statement29 June 2017

JZ Capital Partners Limited (LSE: JZCP.L, the “Company” or “JZCP”), the London listed fund that invests in US and European micro-cap companies and US real estate, today releases its Interim Management Statement for the period 1 March 2017 to 31 May 2017.

Results Highlights

Net Asset Value (“NAV”) of $833.3 million (28/02/17: $848.8 million) NAV per share of $9.93 (28/02/17: $10.12) $43.9 million invested during the period, including: $12.0 million invested in new co-investment Felix Storch $4.5 million follow-on investment in Jordan Health Products $1.2 million net investment in Reflective Apparel Factory (“RAF”), a Technical Services and Solutions (“TSS”) vertical add-on acquisition $16.3 million realised, including: $12.5 million from the first tranche of proceeds for Fidor Bank At the end of the period, the portfolio consisted of 34 micro-cap investments across nine industries and four major real estate “assemblages” (59 total properties) located in New York and South Florida

Strategic Initiatives

In May 2017, JZCP received shareholder approval for certain initiatives designed to maximize shareholder returns, including the discontinuation of the Company’s current dividend policy and inception of a new strategy to allow for the repurchase of shares In April 2017, JZCP increased its loan facility with Guggenheim Partners from approximately $100 million to $150 million in order to provide additional liquidity to JZCP in order to bridge certain planned realisations. The entire $150 million facility may be repaid, in whole or in part, with no penalty after June 2017

David Zalaznick, Founder and Investment Advisor of JZCP said: “Despite the challenging market environment, the strength of our balance sheet has again allowed us to put money to work across the US and European micro-cap and US real estate sectors.

We continue to believe that the US market presents a number of potential realisation opportunities for the Company and we remain confident in the outlook for our diversified portfolio.”

Net Asset Value

NAV per share for the quarter decreased from $10.12 to $9.93, or 1.9%.

NAV Returns

Net Asset Value per Ordinary Share as of 1 March 2017$10.12
Change in NAV per share due to capital gains and income received / accrued on investments
US Micro-cap0.03
European Micro-cap (0.05)
Real Estate (0.06)
Other Investment (0.06)
Other changes in NAV per share
Change in CULS Fair Value (0.01)
Finance Costs (0.06)
Foreign Exchange Effect0.08
Expenses and Taxation (0.04)
Net Asset Value per Ordinary Share as of 31 May 2017 $9.93

The US micro-cap portfolio had a net increase of 3 cents, primarily due to net accrued income of 5 cents and write-ups at our healthcare revenue cycle management vertical (2 cents) and logistics vertical (1 cent). Jordan Health Products was also written up 2 cents. An escrow payment related to our exited co-investment Medplast added 1 cent. Offsetting these uplifts in valuation were decreases in value at our legacy Nationwide Studios business (1 cent) and our ISS vertical (9 cents).

The European micro-cap portfolio had a net decrease of 5 cents, primarily due to 1cent of accrued income offset by a 6 cent write-down at Factor Energia.

The real estate portfolio had a net decrease of 6 cents, primarily due to estimates of debt service, operating costs and other expenses at the property level.

Finally, our other investments had a net decrease of 6 cents, primarily due to a write-down at Spruceview (6 cents).

The chart below summarises the cumulative total NAV returns and total shareholder returns for the most recent three-month, twelve-month, three-year and five-year period.

31/05/17Since 28/02/17Since 31/05/16Since 31/05/14Since 31/05/12
Share price (in GBP)£5.66£5.38£3.90£4.41£3.68
Dividends paid (in USD)$0.16$0.79$1.57
Total Shareholders' return (GBP)15.2%48.9%45.3%95.0%
NAV per share (in USD)$9.93$10.12$10.32$10.08$9.38
NAV per share total returns1(1.9)%(2.3)%6.5%24.2%
NAV to market price discount26%34%45%27%40%

______________

Total returns are cumulative and assume that dividends were reinvested

RECENT ACTIVITIES

Significant Investments and Realisations

US Micro-cap Investments – Verticals

TSS Vertical (formerly known as ‘testing’ vertical)

In May 2017, JZCP invested $1.2 million (investment net of proceeds from refinancing the entire testing vertical) to acquire RAF, which produces high-end reflective apparel purchased by transportation, municipal, construction and industrial customers.

US Micro-cap Investments – Co-investments

In March 2017, JZCP invested a further $4.5 million in Jordan Health Products, to fund the acquisition of Transtate, a business which sells, services, repairs and installs refurbished medical imaging equipment, specializing in catheter angiography equipment.

Also in March 2017, JZCP invested $12.0 million in Felix Storch, a business that manufactures and distributes specialty refrigeration products and appliances.

European Micro-cap Investments

In April and May 2017, JZCP made three short-term loans to EuroMicrocap Fund-B, L.P., totalling $5.4 million, to bridge investments in Docout, Ombuds and One World Packaging.

We expect these loans to be paid back before their stated maturity dates of 31 July 2017.

Real Estate Investments

In the three-month period ended 31 May 2017, JZCP invested a total of $10.4 million in follow-on investments in our Williamsburg Retail, Design District and Greenpoint properties.

Realisations

JZCP sold its interest in Fidor Bank (“Fidor”) to Groupe BPCE, the second largest banking group in France. The transaction closed in December 2016. JZCP invested a total of $13.8 million and is expected to receive total gross proceeds of approximately $25 million from the sale. JZCP received its first tranche of proceeds totalling $12.5 million in March 2017.

PORTFOLIO SUMMARY

At 31 May 2017, the Company’s portfolio consisted of 34 micro-cap investments across nine major industries and four major real estate “assemblages” (59 total properties) located in New York and South Florida.

($’000)At 31/05/17At 28/02/17% Gross Assets 31/05/17
US Micro-cap Portfolio442,147424,50238.9%
European Micro-cap Portfolio162,183154,27714.2%
Real Estate Portfolio474,758468,59941.7%
Other Portfolio15,84421,8021.4%
Total Private Investments1,094,9321,069,18096.2%
Cash42,26229,0643.7%
Total Investments (and Cash)1,137,1941,098,24499.9%
Other Current Assets5965110.1%
Total Investments (and Cash)1,137,7901,098,755100.0%

At 31 May 2017, 3.7% of gross assets were invested in “liquid” assets (cash). The remaining portion of the portfolio was invested in private investments in US or European micro-cap companies or real estate. These investments are valued at fair value by JZCP’s directors each quarter.

We value our privately held businesses carefully. Our average multiple used for our US micro-cap businesses is 8.2x trailing EBITDA. In addition, we do not have substantial debt in these businesses. The multiple of debt senior to JZCP’s position is approximately 3.4x EBITDA.

Top Ten Investments

Our ten largest investments as of 31 May 2017 are summarised below:

($000’s)Asset CategoryValuation 31/05/17% Gross Assets 31/05/17
Design District AssemblageReal Estate100,5708.8%
Industrial Services Solutions VerticalUS77,6536.8%
GreenpointReal Estate75,5246.6%
Healthcare Rev. Cycle Management VerticalUS70,2736.2%
Williamsburg RetailReal Estate68,7186.0%
Fulton AssemblageReal Estate62,0115.5%
EuroMicrocap Fund-C, L.P.European61,0775.4%
TierPointUS46,8134.1%
Jordan Health ProductsUS37,3543.3%
RedBridgeReal Estate36,4453.2%
Top Ten Investments636,43855.9%
Remaining Assets501,35244.1%
Gross Assets1,137,790100.0%

Balance Sheet

Below is a summary of JZCP’s balance sheet as of the relevant dates:

($000’s)31/05/1728/02/17
Cash and cash equivalents42,26229,064
Investments & other assets1,095,5281,069,691
(-) Other net liabilities(247,780)(195,976)
(-) ZDPs due 2022(56,669)(53,935)
Net Asset Value833,341848,844

At 31 May 2017, “other net liabilities” includes $60.2 million from the issuance of Convertible Unsecured Loan Stock (“CULS”) in July 2014, which carries an interest rate of 6%, and $147.6 million from a six-year term loan with Guggenheim Partners, which carries an interest rate of LIBOR plus 5.75%.

For Further Information:

Ed Berry / Kit Dunford +44 (0) 20 3727 1046 / 1143FTI Consulting

David Zalaznick +1 212 485 9410Jordan/Zalaznick Advisers, Inc.

Teresa Le Couteur-Tembo +44 (0) 1481 745741JZ Capital Partners, Ltd.

About JZCP

JZCP is a London listed fund which invests in US and European micro-cap companies and US real estate. Its objective is to achieve an overall return comprised of a current yield and capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. (“JZAI”) which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI’s experts work with the existing management of micro-cap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.

Date   Source Headline
22nd Apr 20243:03 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNProposed Investment in the Secondary Fund for the Purpose of Investing in Follow-on Flex Pack and Proposed Return of Capital and Notice of Extraordinary General Meeting
22nd Mar 20243:00 pmPRNNet Asset Value(s)
21st Feb 202411:55 amPRNNet Asset Value(s)
13th Feb 20249:43 amPRNHolding(s) in Company
22nd Jan 20244:44 pmPRNNet Asset Value(s)
21st Dec 20235:01 pmPRNNet Asset Value(s)
20th Dec 202311:20 amPRNDirector/PDMR Shareholding
18th Dec 20237:00 amPRNRepayment of Senior Facility
14th Dec 20237:00 amPRNUpdate in relation to Secondary Sale
22nd Nov 20235:20 pmPRNNet Asset Value(s)
9th Nov 20237:00 amPRNHalf-year Report
23rd Oct 20232:36 pmPRNNet Asset Value(s)
22nd Sep 20233:09 pmPRNNet Asset Value(s)
21st Aug 20233:00 pmPRNNet Asset Value(s)
25th Jul 20233:59 pmPRNResult of AGM
21st Jul 20233:00 pmPRNNet Asset Value(s)
27th Jun 202310:29 amPRNNotice of AGM
21st Jun 20234:30 pmPRNNet Asset Value(s)
23rd Jun 20224:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20226:26 pmPRNNet Asset Value(s)
23rd May 20227:00 amPRNFurther Update in relation to Secondary Sale
7th Apr 20227:00 amPRNUpdate: Secondary Sale and
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:36 pmRNSPrice Monitoring Extension
23rd Mar 202210:35 amPRNNet Asset Value(s)
21st Mar 20227:00 amPRNJZCP European Micro Cap Investments
21st Feb 202210:28 amPRNNet Asset Value(s)
31st Jan 202211:06 amRNSSecond Price Monitoring Extn
31st Jan 202211:01 amRNSPrice Monitoring Extension
26th Jan 20226:07 pmPRNJZCP Agrees New Senior Facility
21st Jan 20229:34 amPRNNet Asset Value(s)
21st Dec 20219:25 amPRNNet Asset Value(s)
22nd Nov 20219:39 amPRNNet Asset Value(s)
11th Nov 20217:00 amPRNHalf-year Report
9th Nov 202110:00 amPRNNotice of Interim Results
1st Nov 20212:41 pmPRNDirector Declaration
21st Oct 20219:43 amPRNNet Asset Value(s)
7th Oct 20217:00 amPRNSenior Facility Amendments
6th Oct 20212:53 pmPRNDirector Declaration
24th Sep 20219:39 amPRNNet Asset Value(s)
23rd Aug 20219:01 amPRNNet Asset Value(s)
12th Aug 20214:41 pmRNSSecond Price Monitoring Extn
12th Aug 20214:35 pmRNSPrice Monitoring Extension
12th Aug 20212:06 pmRNSSecond Price Monitoring Extn
12th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 202111:23 amPRNIssue of Loan Notes & Shares, Redemption of Loan Stock
21st Jul 20219:51 amPRNNet Asset Value(s)
6th Jul 20212:20 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.